Yakovlev PG - Search Results

1

Changes in expression of TLR-4, TGF-β, INF-γ, TNF-α in cultured T24/83 cells of invasive bladder cancer treated with cisplatin and/or polyphenolic adjuvant melanin.

Yakovlev PG, Gorbach OI, Khranovska NM, Beliayeva AV, Skachkova OV, Skaterna TD, Kalachniuk LG, Ostapchenko LI, Garmanchuk LV. Yakovlev PG, et al. Exp Oncol. 2021 Mar;43(1):7-14. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-1.15739. Exp Oncol. 2021. PMID: 33785718

2

Effect of androgen suppression on bone mineral density in patients with prostate cancer.

Chernichenko OA, Sakalo VS, Yakovlev PG, Sakalo AV, Zhylchuk YV, Zsolt A. Chernichenko OA, et al. Among authors: yakovlev pg. Exp Oncol. 2014 Dec;36(4):276-8. Exp Oncol. 2014. PMID: 25537224

3

Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer.

Yakovlev P, Klyushin D. Yakovlev P, et al. Exp Oncol. 2018 Jun;40(2):119-123. Exp Oncol. 2018. PMID: 29949533

4

Bladder sparing surgery in high-grade bladder cancer.

Yakovlev PG, Klyushin DA, Vereshchako RI. Yakovlev PG, et al. Exp Oncol. 2019 Jun;41(2):160-165. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-2.13207. Exp Oncol. 2019. PMID: 31262149

5

Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage.

Yakovlev PG, Gorbach OI, Ostapchenko LI, Garmanchuk LV, Skachkova OV, Khranovska NM, Senchylo NV. Yakovlev PG, et al. Exp Oncol. 2021 Jun;43(2):142-148. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-2.16102. Exp Oncol. 2021. PMID: 34190522

6

COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER.

Garmanchuk LV, Yakovlev PG, Ostrovska GV, Stupak YA, Skachkova OV, Gorbach OI, Stepanov YV. Garmanchuk LV, et al. Among authors: yakovlev pg. Exp Oncol. 2023 Jun 26;45(1):130-136. doi: 10.15407/exp-oncology.2023.01.130. Exp Oncol. 2023. PMID: 37417273

7

Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer.

Synelnyk T, Vovk T, Halenova T, Tytarenko V, Raksha N, Savchuk O, Falalyeyeva T, Ostapchenko L, Yakovlev P, Kozyk M, Thorley D, Strubchevska K. Synelnyk T, et al. Front Med (Lausanne). 2023 Nov 15;10:1276882. doi: 10.3389/fmed.2023.1276882. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034543 Free PMC article.

8

Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial.

Colombel M, Heidenreich A, Martínez-Piñeiro L, Babjuk M, Korneyev I, Surcel C, Yakovlev P, Colombo R, Radziszewski P, Witjes F, Schipper R, Mulders P, Witjes WP. Colombel M, et al. Eur Urol. 2014 Mar;65(3):509-11. doi: 10.1016/j.eururo.2013.10.056. Epub 2013 Nov 11. Eur Urol. 2014. PMID: 24268503

9

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.

Mulders PFA, Martínez-Piñeiro L, Heidenreich A, Babjuk M, Colombel M, Colombo R, Radziszewski P, Korneyev I, Surcel C, Yakovlev P, Witjes JA, Caris C, Schipper R, Witjes WPJ; MAGNOLIA Study Group of the EAU Research Foundation. Mulders PFA, et al. Eur Urol Focus. 2019 Sep;5(5):849-852. doi: 10.1016/j.euf.2018.02.005. Epub 2018 Feb 21. Eur Urol Focus. 2019. PMID: 29477797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters